SunWay Biotech Co., LTD. (TPEX:1271)

Taiwan · Delayed Price · Currency is TWD

64.00

-4.30 (-6.30%)

At close: Jul 9, 2026

4.92% (1Y)

Market Cap	3.86B +6.7%
Revenue (ttm)	993.30M +2.4%
Net Income	101.50M -14.4%
EPS	1.68 -14.3%
Shares Out	60.39M
PE Ratio	38.10
Forward PE	n/a
Dividend	1.00 (1.46%)
Ex-Dividend Date	Jul 16, 2025

Volume	166,299
Open	68.70
Previous Close	68.30
Day's Range	63.20 - 69.00
52-Week Range	51.00 - 90.80
Beta	-0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company offers red yeast rice and lactic acid bacteria products, as well as other health supplements; and wholesale and manufacturing of pharmaceutical products. The company also researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan. [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2007

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 1271

Full Company Profile

Financial Performance

In 2025, SunWay Biotech Co., LTD.'s revenue was 993.30 million, an increase of 2.38% compared to the previous year's 970.18 million. Earnings were 101.50 million, a decrease of -14.40%.

Financial Statements